Åke Borg
271 – 280 of 394
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors
(
- Contribution to journal › Article
-
Mark
Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations
(
- Contribution to journal › Article
- 2004
-
Mark
BRCA2 mutations in 154 Finnish male breast cancer patients
(
- Contribution to journal › Article
-
Mark
Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells.
(
- Contribution to journal › Article
-
Mark
Melanoma and nonmelanoma skin cancer in patients with multiple tumours-evidence for new syndromes in a population-based study.
(
- Contribution to journal › Article
-
Mark
Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior.
(
- Contribution to journal › Article
-
Mark
Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles.
(
- Contribution to journal › Article
-
Mark
A familial syndromic association between cutaneous malignant melanoma and neural system tumours: reply from authors
(
- Contribution to journal › Letter
-
Mark
Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation
(
- Contribution to journal › Article
-
Mark
One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations : results of a prospective study in Southern Sweden
(
- Contribution to journal › Article